Circulating regulatory (CD4+CD25+FOXP3+) T cells decrease in breast cancer patients after vaccination with an Ii-Key-modified class II HER2/neu peptide (AE37).
Year: 2009
Type: conference-abstract
Source: Cancer Research
Authors: JD Gates, LC Benavides, MG Carmichael, MT Hueman, JP Holmes, S Khoo, A Stojadinovic, E von Hofe, S Ponniah, GE Peoples
Language: English
Topic: T-cell and B-cell Immunology
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W2003759383